Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-05-10 Sale | 2023-05-11 4:12 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 210 | $3.31 | $695 | 15,992 (Direct) | View |
2023-01-20 Purchase | 2023-01-24 4:30 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,923,076 | $13 | $24,999,988 | 11,609,704 (Indirect) | View |
2023-01-13 Sale | 2023-01-13 6:33 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO | 6,766 | $15 | $101,490 | 499,864 (Direct) | View |
2023-01-04 Purchase | 2023-01-06 4:39 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 180,703 | $7.2761 | $1,314,806 | 9,686,628 (Indirect) | View |
2022-12-27 Purchase | 2022-12-29 5:00 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 4,089 | $5.9941 | $24,510 | 9,505,925 (Indirect) | View |
2022-12-19 Purchase | 2022-12-21 4:30 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 98,787 | $5.8997 | $582,814 | 9,501,836 (Indirect) | View |
2022-12-14 Purchase | 2022-12-16 4:41 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 2,403,049 | $5.4405 | $13,073,874 | 9,403,049 (Indirect) | View |
2022-06-07 Sale | 2022-06-08 7:33 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 71,435 | $8.0898 | $577,895 | 593,153 (Direct) | View |
2022-06-02 Sale | 2022-06-06 7:00 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 66,622 | $7.9975 | $532,810 | 1,054,819 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-08-07 Option Award | 2023-08-09 4:16 pm | N/A 2033-08-06 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 432,800 | $0 | 432,800 (Direct) | View |
Ownership | 2023-08-09 4:11 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2023-07-03 4:16 pm | N/A 2033-05-11 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 0 | $0 | 2,430,400 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:23 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-04-26 Option Award | 2023-04-28 4:17 pm | N/A 2033-04-25 | Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer | 115,000 | $0 | 115,000 (Direct) | View |
2023-04-26 Option Award | 2023-04-28 4:16 pm | N/A 2033-04-25 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 127,500 | $0 | 127,500 (Direct) | View |
2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller | 16,100 | $0 | 16,100 (Direct) | View |
2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer | 135,000 | $0 | 135,000 (Direct) | View |
2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
2022-12-13 Other | 2022-12-15 4:30 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner | 2,000,000 | $0 | 6,461,545 (Direct) | View |
2022-11-07 Option Award | 2022-11-09 4:15 pm | N/A 2032-11-06 | Fulcrum Therapeutics Inc. | FULC | Arroyo Santiago Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2022-11-09 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Arroyo Santiago Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2022-08-26 4:39 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 0 | $0 | 7,000,000 (Indirect) | View |
2022-08-09 Option Award | 2022-08-11 4:15 pm | N/A 2032-08-08 | Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer | 137,000 | $0 | 137,000 (Direct) | View |
2022-08-09 Option Award | 2022-08-11 4:15 pm | N/A 2032-08-08 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2022-08-11 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer | 0 | $0 | 190,000 (Direct) | View |
2022-07-15 Option Award | 2022-07-19 4:15 pm | N/A 2032-07-14 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller | 16,540 | $0 | 16,540 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director | 19,000 | $0 | 33,500 (Direct) | View |
2022-06-28 Other | 2022-06-29 5:00 pm | N/A 2030-12-02 | Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director | 500 | $0 | 33,500 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-07 Exercise | 2022-06-08 7:33 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 71,435 | $7.84 | 593,153 (Direct) | View |
2022-06-07 Exercise | 2022-06-08 7:33 pm | N/A 2022-06-30 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 71,435 | $0 | 593,153 (Direct) | View |
2022-06-02 Exercise | 2022-06-06 7:00 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 66,622 | $7.84 | 1,054,819 (Direct) | View |
2022-06-02 Exercise | 2022-06-06 7:00 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 66,622 | $0 | 1,054,819 (Direct) | View |